{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:29:10Z","timestamp":1761290950954,"version":"3.38.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.surg.2011.07.020","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T01:29:09Z","timestamp":1318555749000},"page":"162-170","source":"Crossref","is-referenced-by-count":26,"title":["Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases"],"prefix":"10.1016","volume":"151","author":[{"given":"Shishir K.","family":"Maithel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"DeMatteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuman","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie H.","family":"Blumgart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I.","family":"D'Angelica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2011.07.020_bib1","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","article-title":"Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial","volume":"24","author":"Portier","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2011.07.020_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A\u00a0randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib5","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1200\/JCO.2001.19.23.4298","article-title":"ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy","volume":"19","author":"Shirota","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib6","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/ijc.22129","article-title":"Molecular determinants of irinotecan efficacy","volume":"119","author":"Vallbohmer","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.surg.2011.07.020_bib7","first-page":"1257","article-title":"Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis","volume":"33","author":"Kobayashi","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.2003.06.060","article-title":"Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer","volume":"21","author":"Gonen","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib9","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1200\/JCO.2007.15.5580","article-title":"Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial","volume":"26","author":"Braun","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1200\/JCO.2004.05.064","article-title":"Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis","volume":"22","author":"Popat","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2011.07.020_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/sj.bjc.6604317","article-title":"ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen","volume":"98","author":"Wei","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.surg.2011.07.020_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.canlet.2008.02.049","article-title":"c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases","volume":"265","author":"Zeng","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.surg.2011.07.020_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2011.07.020_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-7-3","article-title":"The RIN: an RNA integrity number for assigning integrity values to RNA measurements","volume":"7","author":"Schroeder","year":"2006","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.surg.2011.07.020_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/2532742","article-title":"Prediction in censored survival data: a comparison of the proportional hazards and linear regression models","volume":"48","author":"Heller","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.surg.2011.07.020_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","article-title":"An analysis of transformations","volume":"B26","author":"Box","year":"1964","journal-title":"Journal of the Royal Statistical Society"},{"key":"10.1016\/j.surg.2011.07.020_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2307\/2529881","article-title":"Maximally selected chi square statistics","volume":"82","author":"Miller","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.surg.2011.07.020_bib18","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2011.07.020_bib19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2011.07.020_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ctrv.2007.07.001","article-title":"Current status of excision repair cross complementing-group 1 (ERCC1) in cancer","volume":"33","author":"Gossage","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.surg.2011.07.020_bib21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2011.07.020_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canlet.2006.07.007","article-title":"Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome","volume":"248","author":"Kammula","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.surg.2011.07.020_bib23","first-page":"1407","article-title":"Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors","volume":"55","author":"Johnston","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.surg.2011.07.020_bib24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10620-007-0008-x","article-title":"Prognostic and predictive value of thymidylate synthase expression in colon cancer","volume":"53","author":"Tsourouflis","year":"2008","journal-title":"Dig Dis Sci"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606011003710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606011003710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T22:05:42Z","timestamp":1741817142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606011003710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0039606011003710"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2011.07.020","relation":{},"ISSN":["0039-6060"],"issn-type":[{"type":"print","value":"0039-6060"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}